Early Day Motion·EDM 208
Enhertu for metastatic breast cancer patients
1 June 20261 Signature
Primary sponsor
Clive Jones
Liberal Democrat — Wokingham
Motion Text
That this House recognises the recent changes to NICE’s cost effectiveness threshold, which could facilitate better access to new medicines; expresses concern that Enhertu, a treatment for people with incurable HER2-low metastatic breast cancer, remains unavailable to patients on the NHS in England; welcomes Breast Cancer Now's Enhertu Now campaign, supported by METUPUK and Make 2nds Count; and urges pharmaceutical companies Daiichi Sankyo and AstraZeneca, NHS England and NICE to reach a deal to make Enhertu available to those who urgently need it to give them more time to live.